Featured Paper of the Month

Modification of Brain Connectome on Association Between Adverse Childhood Experiences and Development of Mental Disorders in Preadolescence

Featured Paper of the Month – April 2026
Published in JAMA Network Open by Xiang Xiao and Yihong Yang et al. of the NIDA IRP Magnetic Resonance Imaging and Spectroscopy Section.

In this study, we addressed the question of whether a brain marker moderates the association between childhood adversity and psychiatric disorders during the transition to adolescence.

Distinct Amygdala Neuronal Populations Control Opioid Use and Withdrawal in Mice.

Featured Paper of the Month – March 2026
Published in Biological Psychiatry by Lucas Silva Tortorelli and Leandro Vendruscolo et al. of the NIDA IRP Stress and Addiction Neuroscience Unit.

We used in situ hybridization to characterize the expression of μ opioid receptor (MOR) (Oprm1), and we used behavioral and molecular approaches to assess the functional role of these CeA neuronal populations in opioid-dependent mice.

Latent Classes of Adverse Childhood Experiences (ACEs) and Adult Substance-use Problems and Psychosocial Outcomes: Complex and Heterogeneous Associations.

Featured Paper of the Month – February 2026
Published in International Journal of Mental Health and Addiction by Emily Herberholz, Rachel Wolchok an David Epstein, et al. of the NIDA IRP Real-world Assessment, Prediction, and Treatment Section.

In this paper, we first showed that we could categorize people by specific patterns/types of ACE exposure, providing a more informative summary than the older approach of just tallying up each person’s total number of types of ACEs. Then we showed that even though ACE exposure can predict later SUD symptoms to a statistically significant degree in people who use alcohol or other drugs, the predictions are too imprecise for case-by-case decision-making

Distinct prelimbic cortex ensembles encode response execution and inhibition.

Featured Paper of the Month – January 2026
Published in PNAS by Rajtarun Madangopal, Ph.D. and Bruce Hope, Ph.D. of the NIDA IRP Neuronal Ensembles in Drug Addiction Section.

In this study, researchers used single-cell calcium imaging to longitudinally track hundreds of brain cells (neurons) in rats across three phases: when they pressed a lever for food rewards (Training), as they learned to stop pressing when the reward was removed (Extinction), and when they resumed pressing after a small, non-contingent reward was reintroduced (Reinstatement). Analyses showed that distinct and non-overlapping populations – called ensembles – were active during Training and Extinction, to support response execution and inhibition, respectively.

A novel atypical DAT inhibitor that inhibits cocaine taking and seeking and itself has low abuse potential in experimental animals.

Featured Paper of the Month – December 2025
Published in Translational Psychiatry by Omar Soler-Cedeño and Zheng-Xiong Xi, M.D., Ph.D. of the NIDA IRP Addiction Biology Unit.

This study evaluated two new compounds in animal models: RDS-04-010, an atypical dopamine transporter (DAT) inhibitor that binds to an inward-facing conformation of DAT, and RDS-03-094, a more typical DAT inhibitor that binds to an outward-facing conformation. Notably, RDS-04-010 reduced cocaine use, lowered motivation to seek cocaine, and prevented relapse-like behavior, while showing no rewarding or addictive effects on its own. These findings highlight RDS-04-010 as a promising treatment candidate.

Brain reactivity to nicotine cues mediates the link between resting-state connectivity and cue-induced craving in individuals who smoke or vape nicotine

Featured Paper of the Month – November 2025
Published in Neuropsychopharmacology by Laura Murray and Amy Janes of the NIDA IRP Cognitive and Pharmacological Neuroimaging Section.

This project tested whether brain and subjective responses to nicotine cues differed between individuals who smoke versus vape nicotine, and whether brain function at rest was related to how the brain responded to nicotine cues and how exposure to nicotine cues influences subjective craving.

Characterizing Olfactory Brain Responses in Young Infants

Featured Paper of the Month – October 2025
Published in The Journal of Neuroscience by Thorsten Kahnt of the NIDA IRP Learning and Decision-Making Section.

In this study, we presented different odors to sleeping infants while recording their nasal airflow and brain activity using functional magnetic resonance imaging (fMRI). Odors evoked strong fMRI responses throughout the olfactory cortex and thalamus. Moreover, analysis of nasal airflow showed that infants inhaled more strongly to pleasant compared to unpleasant odors, suggesting they may adjust their breathing based on odor preference.

Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-,-dimethyltryptamine Analogs in Mice

Featured Paper of the Month – September 2025
Published in ACS Chemica Neuroscience by Grant Glatfelter and Michael Baumann of the NIDA IRP Designer Drug Research Unit.

In this study, we show that 5-MeO-DMT and related analogs potently activate 5-HT1A receptors, which tend to decrease the magnitude of 5-HT2A-mediated behavioral effects in mice.

The Role of Claustrum in Incubation of Opioid Seeking after Electric Barrier-Induced Voluntary Abstinence in Male and Female Rats

Featured Paper of the Month – August 2025
Published in Journal of Neuroscience by Kenichiro Negishi, Ying Duan, Yihong Yang, Yavin Shaham and Ida Fredriksson, et al. of the NIDA IRP Magnetic Resonance Imaging and Spectroscopy Section and Neurobiology of Relapse Section.

In the present study, we used immunohistochemistry, anatomical tracing, and reversible inactivation methods to identify a critical role of a brain region called the claustrum and its anatomical connections with ventral subiculum in incubation of oxycodone seeking.

Glucagon-like peptide-1 receptor agonists but not dipeptidyl peptidase-4 inhibitors reduce alcohol intake

Featured Paper of the Month – July 2025

Published in Journal of Clinical Investigation by Mehdi Farokhnia and Lorenzo Leggio of the NIDA IRP Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section.

In this study, we investigated the associations between the receipt of GLP-1RAs and change in alcohol use, using real-world electronic health record data from the largest integrated healthcare system in the U.S., the Department of Veterans Affairs (VA).